Integra Lifesciences Holdings Corp
IART- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000917520
No open-market purchases or sales by Integra Lifesciences Holdings Corp insiders were filed in the last 90 days; 212 institutions reported holding it in 13F filings for Q2 2026, worth $1.32B in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 11, 2026
- $1.15B
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +13 vs. previous quarter
- 212
- 13F valueReported value at the end of Q2 2026
- $1.32B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $1.64B
- +1.5% year over year
- Net income, FY2025
- -$516.5M
- No comparable prior period
- Free cash flow, FY2025
- -$31.1M
- −224.4% year over year
- Revenue, Q3 FY2026
- $411.2M
- +2.3% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2025: $516.5M (31.6% of revenue).
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 7.90M
- Shares sold short
- Change
- +578.7K
- +7.9% vs. previous
- Days to cover
- 6.37
- At average daily volume
Superinvestors holding IART, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding IART at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Integra Lifesciences Holdings Corp insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 6, 2025 (view filing) | Nov 5 | 1 day | Graves Jeffrey ADirector | PPurchase | +9.00K | $11.35 | +$102.2K | +28.0%41.1K after | |
| Dec 4, 2024 (view filing) | Dec 3 | 1 day | Schwartz EricEVP, Chief Legal Officer & Sec | SSale | −4.07K | $24.60 | −$100.1K | −6.4%59.5K after | |
| Dec 3, 2024 (view filing) | Dec 2 | 1 day | McBreen Michael J.EVP & President, CSS | SSale | −1.70K | $24.16 | −$41.1K | −2.9%56.2K after | |
| Aug 20, 2024 (view filing) | Aug 19 | 1 day | Mosebrook JeffreySVP, Fin & Princ Acct Officer | SSale | −1.19K | $21.58 | −$25.7K | −3.2%36.1K after | |
| May 24, 2024 (view filing) | May 23 | 1 day | Essig StuartExec. Chairman of the Board | PPurchase | +52.6K | $28.49 | +$1.50M | +12.1%487.9K after | |
| May 22, 2024 (view filing) | May 21 | 1 day | Hill Barbara BDirector | PPurchase | +36.4K | $27.40 | +$996.0K | New position36.4K after | |
| Mar 8, 2024 (view filing) | Mar 6 | 2 days | Davis Robert T. Jr.EVP & President, TT | SSale | −8.35K | $36.59 | −$305.5K | −14.3%49.9K after | |
| Aug 10, 2023 (view filing) | Aug 9 | 1 day | Mosebrook JeffreySVP, Fin & PAO | SSale | −1.18K | $44.46 | −$52.3K | −4.8%23.5K after | |
| Jun 5, 2023 (view filing) | Jun 1 | 4 days | Schwartz EricEVP, Chief Legal Officer & Sec | PPurchase | +2.64K | $37.89 | +$100.0K | +5.7%48.6K after | |
| Jun 2, 2023 (view filing) | Jun 1 | 1 day | De Witte JanPresident & CEO | PPurchase | +7.79K | $38.50 | +$300.0K | +155.7%12.8K after |
Top 10 13F holders, Q2 2026
See all 212 holdersThe largest institutional positions in Integra Lifesciences Holdings Corp at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 10,684,103 | $191.9M | 0.00% | +364,934+3.5% | Added |
| Rubric Capital Management LP | 7,753,934 | $139.3M | 1.28% | 00.0% | Unchanged |
| Invesco Ltd. | 3,749,367 | $67.3M | 0.01% | +263,764+7.6% | Added |
| Vanguard Portfolio Management LLC | 3,743,093 | $67.2M | 0.00% | +56,456+1.5% | Added |
| Morgan Stanley | 3,593,079 | $64.5M | 0.00% | +8,924+0.2% | Added |
| Paradigm Capital Management Inc | 3,439,098 | $61.8M | 1.68% | −573,600−14.3% | Reduced |
| Fuller & Thaler Asset Management, Inc. | 3,436,006 | $61.7M | 0.17% | −93,398−2.6% | Reduced |
| State Street Corp | 2,946,862 | $52.9M | 0.00% | +60,306+2.1% | Added |
| Vanguard Capital Management LLC | 2,946,173 | $52.9M | 0.00% | +55,349+1.9% | Added |
| Neuberger Berman Group LLC | 2,364,777 | $42.6M | 0.03% | +249,522+11.8% | Added |
Holders of 5% or more of IART
See all 4 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Integra Lifesciences Holdings Corp.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 13.20%10.3M shares | – | Jul 17, 20251 filing | Jul 17, 2025 | SEC |
| Rubric Capital Management LP | 13G/A | 9.46%7.35M shares | +3.45 ppfrom 6.01% | May 14, 20252 filings | Jul 9, 2025 | SEC |
| Invesco Ltd. | 13G | 5.40%4.16M shares | +0.90 ppfrom 4.50% | May 9, 20253 filings | Nov 10, 2026 | SEC |
| Vanguard Portfolio Management LLC | 13G | 5.02%3.91M shares | New | Jul 31, 20261 filing | Jul 31, 2026 | SEC |
Politician trades
All politician trades in IART3 members of Congress reported 11 trades in Integra Lifesciences Holdings Corp since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Jul 9, 2024 |  Josh Gottheimer House · NJ | Sell (partial) | $1K-$15K |
| May 15, 2024 | Josh Gottheimer House · NJ | Sell (partial) | $1K-$15K |
| Nov 11, 2023 | Josh Gottheimer House · NJ | Buy | $1K-$15K |
| Oct 15, 2023 | Josh Gottheimer House · NJ | Sell (partial) | $1K-$15K |
| Jul 11, 2023 | Josh Gottheimer House · NJ | Sell (partial) | $1K-$15K |
House · NJ · Jul 9, 2024
Sell (partial)$1K-$15K
House · NJ · May 15, 2024
Sell (partial)$1K-$15K
House · NJ · Nov 11, 2023
Buy$1K-$15K
House · NJ · Oct 15, 2023
Sell (partial)$1K-$15K
House · NJ · Jul 11, 2023
Sell (partial)$1K-$15K